Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Moderna And 2 Other Stocks Insiders Are Selling

Published 25/07/2022, 12:45
© Reuters.  Moderna And 2 Other Stocks Insiders Are Selling

US manufacturing PMI dropped to 52.3 in July from previous reading of 52.70, while services PMI tumbled to 47.00 from 52.70. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Jabil

  • The Trade: Jabil Inc. (NYSE: JBL) EVP, GC, CCO & Assist Corp Sec Robert Katz sold a total of 9,477 shares at an average price of $55.00. The insider received around $521.24 thousand from selling those shares.
  • What’s Happening: IdentifySensors Biologics partnered with Jabil Healthcare to manufacture digital diagnostic platform.
  • What Jabil Does: Jabil Inc is a United States-based company engaged in providing manufacturing services and solutions. It provides comprehensive electronics design, production and product management services to companies in various industries and end markets.

Moderna (NASDAQ:MRNA)

  • The Trade: Moderna, Inc. (NASDAQ: MRNA) Director Noubar B. Afeyan sold a total of 10,000 shares at an average price of $167.00. The insider received around $1.67 million as a result of the transaction.
  • What’s Happening: European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending a variation to the conditional marketing authorization (CMA) to include a booster dose of Moderna’s Spikevax, COVID-19 vaccine, at the 50 µg dose level for adolescents (12-17 years) at least three months after completion of the primary series.
  • What Moderna Does: Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Lennar

  • The Trade: Lennar Corporation (NYSE: NYSE:LEN) VP and Controller David M Collins sold a total of 15,000 shares at an average price of $82.00. The insider received around $1.23 million from selling those shares.
  • What’s Happening: JP Morgan recently downgraded Lennar from Overweight to Neutral and lowered the price target from $83 to $80.
  • What Lennar Does: Lennar is the second-largest public homebuilder in the United States.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.